    In the United States Court of Federal Claims
                                OFFICE OF SPECIAL MASTERS
                                          No. 14-883V
                                     Filed: March 29, 2016
                                      Not for Publication

*************************************
MATTHEW McLAUGHLIN,                           *
                                              *
               Petitioner,                    *
                                              *
 v.                                           *    Attorneys’ fees and costs decision;
                                              *    respondent does not object
SECRETARY OF HEALTH                           *
AND HUMAN SERVICES,                           *
                                              *
               Respondent.                    *
                                              *
*************************************
Jeffrey S. Pop, Beverly Hills, CA, for petitioner.
Gordon Shemin, Washington, DC, for respondent.

MILLMAN, Special Master


                    DECISION AWARDING ATTORNEYS’ FEES AND COSTS 1

        On September 22, 2014, petitioner filed a petition for compensation under the National
Childhood Vaccine Injury Act, 42 U.S.C. §§ 300aa-10–34 (2012). Petitioner alleged that he
suffered from Chronic Inflammatory Demyelinating Polyneuropathy (“CDIP”) caused by his
receipt of the hepatitis A, Menactra, and HPV vaccines on or about May 2, 2012. On March 24,
2016, the undersigned issued a decision awarding compensation to petitioner based on the parties’
stipulation.

        On March 28, 2016, petitioner filed a motion for attorneys’ fees and costs. Petitioner

1
  Because this unpublished decision contains a reasoned explanation for the special master’s action in this
case, the special master intends to post this unpublished decision on the United States Court of Federal
Claims’ website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal
Management and Promotion of Electronic Government Services). Vaccine Rule 18(b) states that all
decisions of the special masters will be made available to the public unless they contain trade secrets or
commercial or financial information that is privileged and confidential, or medical or similar information
whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is
filed, petitioner has 14 days to identify and move to redact such information prior to the document=s
disclosure. If the special master, upon review, agrees that the identified material fits within the banned
categories listed above, the special master shall redact such material from public access.
requests attorneys’ fees in the amount of $22,395.00 and attorneys’ costs in the amount of
$2,989.21. Petitioner also asks for $3,250.00 to pay his expert, Dr. Sykes. Therefore, petitioner
asks for a total amount of $28,634.21. In compliance with General Order #9, petitioner has filed a
signed statement indicating petitioner incurred no out-of-pocket expenses. Petitioner’s motion
indicated that respondent does not object to the undersigned awarding petitioner $28,634.21 in
attorneys’ fees and costs. On March 29, 2016, the undersigned’s law clerk contacted
respondent’s counsel, who confirmed respondent has no objections to petitioner’s motion.

       The Vaccine Act permits an award of “reasonable attorneys’ fees” and “other costs.”
42 U.S.C. § 300aa-15(e)(1). Based on the reasonableness of petitioner’s request and the lack of
opposition from respondent, the undersigned GRANTS petitioner’s motion for attorneys’ fees and
costs. The undersigned awards $28,634.21, representing reimbursement for attorneys’ fees and
costs. The award shall be in the form of a check made payable jointly to petitioner and Jeffrey S.
Pop & Associates in the amount of $28,634.21.

        In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the
court is directed to enter judgment herewith. 2


IT IS SO ORDERED.


Dated: March 29, 2016                                                              s/ Laura D. Millman
                                                                                      Laura D. Millman
                                                                                       Special Master




2
  Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or
jointly, filing a notice renouncing the right to seek review.
                                                    2
